|
|||||
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| TECH | Kelderman Kim | Chief Executive Officer | Aug 15 '25 | Option Exercise | 0.00 | 8,543 | 0 | 55,273 | Aug 19 05:28 PM |
| TECH | Kelderman Kim | Chief Executive Officer | Jul 22 '25 | Option Exercise | 44.33 | 48,176 | 2,135,642 | 90,379 | Jul 24 04:26 PM |
| TECH | Kelderman Kim | Chief Executive Officer | Jul 15 '25 | Option Exercise | 44.33 | 36,132 | 1,601,732 | 75,136 | Jul 17 05:04 PM |
| TECH | Kelderman Kim | Chief Executive Officer | Jan 27 '25 | Option Exercise | 37.70 | 13,392 | 504,878 | 52,396 | Jan 29 04:35 PM |
| TECH | Kelderman Kim | Chief Executive Officer | Jan 27 '25 | Sale | 77.29 | 13,392 | 1,035,013 | 39,004 | Jan 29 04:35 PM |
| TECH | KIM KELDERMAN | Director | Jan 27 '25 | Proposed Sale | 77.05 | 13,392 | 1,031,854 | Jan 27 04:24 PM | |
| TECH | Kelderman Kim | Chief Executive Officer | Aug 29 '24 | Option Exercise | 66.97 | 1,492 | 99,919 | 41,434 | Sep 03 04:05 PM |
| TECH | Kelderman Kim | Chief Executive Officer | Jul 31 '24 | Option Exercise | 37.70 | 14,000 | 527,800 | 49,421 | Aug 02 04:17 PM |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Aug 24 '23 | Option Exercise | 47.60 | 2,100 | 99,960 | 21,225 | Aug 28 04:19 PM |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Aug 05 '23 | Option Exercise | 0.00 | 8,060 | 0 | 23,264 | Aug 08 05:28 PM |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Aug 23 '22 | Option Exercise | 150.78 | 663 | 99,967 | 3,801 | Aug 25 05:38 PM |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Feb 08 '22 | Option Exercise | 150.78 | 1,989 | 299,901 | 1,989 | Feb 10 04:31 PM |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Nov 19 '21 | Option Exercise | 150.78 | 500 | 75,390 | 500 | Nov 23 08:02 PM |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Nov 19 '21 | Sale | 505.38 | 500 | 252,689 | 0 | Nov 23 08:02 PM |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Sep 22 '21 | Sale | 529.04 | 822 | 434,871 | 0 | Sep 24 04:30 PM |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Aug 08 '21 | Option Exercise | 0.00 | 1,691 | 0 | 1,691 | Aug 10 06:21 PM |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Jun 09 '21 | Sale | 433.00 | 811 | 351,163 | 0 | Jun 11 04:59 PM |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | May 25 '21 | Sale | 424.00 | 845 | 358,280 | 811 | May 27 04:26 PM |
| TECH | Kelderman Kim | Pres. Diagnostics & Genom | Feb 05 '21 | Sale | 388.45 | 823 | 319,694 | 845 | Feb 09 06:31 PM |
| TECH | Kelderman Kim | President, Diagnostics & Genom | May 01 '19 | Option Exercise | 202.13 | 1,667 | 336,951 | 1,667 | May 02 04:18 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite